Study of therapeutic effect of different concentrations of imatinib on Balb/c model of cutaneous leishmaniasis

Leishmaniasis, as a tropical and subtropical disease, is endemic in more than 90 countries around the world. Today, cutaneous leishmaniasis (CL) that affects more than 1.5 million people per year lacks a definitive treatment approach. Imatinib is an anticancer drug that inhibits the abnormal functio...

Descripción completa

Detalles Bibliográficos
Autores principales: Moslehi, Mohsen, Namdar, Fatemeh, Esmaeilifallah, Mahsa, Iraji, Fariba, Vakili, Bahareh, Sokhanvari, Fatemeh, Hosseini, Seyed-Mohsen, Khamesipour, Faham, Sebghatollahi, Zahra, Hejazi, Sayed-Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AIMS Press 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326727/
https://www.ncbi.nlm.nih.gov/pubmed/32617447
http://dx.doi.org/10.3934/microbiol.2020010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326727/
https://www.ncbi.nlm.nih.gov/pubmed/32617447
http://dx.doi.org/10.3934/microbiol.2020010

Ejemplares similares